Hantaviruses and TNF-alpha act synergistically to induce ERK1/2 inactivation in Vero E6 cells

Virology Journal

Volumn 5, Issue , 2008, Pages

  Strandin, Tomas ^a   Hepojoki, Jussi ^a   Wang, Hao ^a   Vaheri, Antti ^a   Lankinen, Hilkka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HANTAVIRUS; KIDNEY DYSFUNCTION; NONHUMAN; PATHOGENESIS; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEINURIA; SIGNAL TRANSDUCTION; VERO CELL; VIRUS HEMORRHAGIC FEVER; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; APOPTOSIS; CERCOPITHECUS; DRUG ANTAGONISM; IMMUNOLOGY;

HANTAVIRUS; PUUMALA; TULA VIRUS;

ANIMALS; APOPTOSIS; CERCOPITHECUS AETHIOPS; HANTAVIRUS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; TUMOR NECROSIS FACTOR-ALPHA; VERO CELLS;

EID: 54049131193     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-110     Document Type: Article

References (39)

1. Hantaviruses: a global disease problem. C Schmaljohn B Hjelle, Emerg Infect Dis 1997 3 95 104 9204290
2. Hantavirus infections in Europe. O Vapalahti J Mustonen Å Lundkvist H Henttonen A Plyusnin A Vaheri, Lancet Infect Dis 2003 3 653 661 10.1016/S1473-3099(03)00774-6 14522264
3. Hantaviruses: genome structure, expression and evolution. A Plyusnin O Vapalahti A Vaheri, J Gen Virol 1996 77 2677 2687 10.1099/0022-1317-77-11-2677 8922460
4. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. M Linderholm C Ahlm B Settergren A Waage A Tarnvik, J Infect Dis 1996 173 38 43 8537680
5. Dynamic changes of apoptosis-inducing ligands and Th1/Th2 like subpopulations in Hantaan virus-induced hemorrhagic fever with renal syndrome. JM Liu Y Zhu ZW Xu WM Quyang JP Wang XS Liu YX Cao Q Li L Fang R Zhuang AG Yang BQ Jin, Clin Immunol 2006 119 245 251 10.1016/j.clim.2006.02.010 16616877
6. Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. AA Borges GM Campos ML Moreli RL Souza VH Aquino FP Saggioro LT Figueiredo, Microbes Infect 2006 8 2324 2330 10.1016/j.micinf.2006.04.019 16793309
7. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. M Temonen J Mustonen H Helin A Pasternack A Vaheri H Holthöfer, Clin Immunol Immunopathol 1996 78 47 55 10.1006/clin.1996.0007 8599883
8. Implications of the analogy between recombinant cytokine toxicities and manifestations of hantavirus infections. BM Wimer, Cancer Biother Radiopharm 1998 13 193 207 10850356
9. Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. S Mäkelä M Hurme J Ala-Houhala J Mustonen AM Koivisto J Partanen O Vapalahti A Vaheri A Pasternack, Nephrol Dial Transplant 2001 16 1368 1373 10.1093/ndt/16.7.1368 11427627
10. Tumor necrosis factor signaling. H Wajant K Pfizenmaier P Scheurich, Cell Death Differ 2003 10 45 65 10.1038/sj.cdd.4401189 12655295
11. Tula hantavirus infection in Vero E6 cells induces apoptosis involving caspase-8 activation. XD Li S Kukkonen O Vapalahti A Plyusnin H Lankinen A Vaheri, J Gen Virol 2004 85 3261 3268 10.1099/vir.0.80243-0 15483239
12. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. C Widmann S Gibson MB Jarpe GL Johnson, Physiol Rev 1999 79 1 143 180 9922370
13. Regulation of cell cycle progression and apoptosis by the RAS/RAF/MEK/ERK pathway (Review). F Chang LS Steelman JG Shelton JT Lee PM Navolanic WL Blalock R Franklin JA McCubrey, Int J Oncol 2003 22 3 469 480 12579299
14. Fibroblast growth factor-2 suppression of tumor necrosis factor-α mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. AM Gardner GL Johnson, J Biol Chem 1996 271 14560 14566 10.1074/jbc.271.24.14560 8662985
15. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-α induced endothelial apoptosis. S Grethe I Pörn-Ares, Cell Signal 2006 18 531 540 10.1016/j.cellsig.2005.05.023 15972258
16. Suppression of coronavirus replication by inhibition of the MEK signaling pathway. Y Cai Y Liu X Zhang, J Virol 2007 81 446 456 17079328 10.1128/JVI.01705-06
17. A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplicitation. JC de Magalhaes AA Andrade PNG Silva LP Sousa C Ropert PCP Ferreira EG Kroon T Gazzineli CA Bonjardim, J Biol Chem 2001 276 38353 38360 10.1074/jbc.M100183200 11459835
18. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. S Pleschka T Wolff C Ehrhardt G Hobom O Planz UR Rapp S Ludwig, Nat Cell Biol 2001 3 301 305 10.1038/35060098 11231581
19. Adenovirus-induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny. M Schumann M Dobbelstein, Cancer Res 2006 66 1282 1288 10.1158/0008-5472.CAN-05-1484 16452180
20. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. N Sharma-Walia HH Krishnan PP Naranatt L Zeng MS Smith B Chandran, J Virol 2005 79 10308 10329 16051824 10.1128/JVI.79.16.10308-10329.2005
21. HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis-involvement of ERK pathway. J Wang YH Shen B Utama J Wang SA LeMaire JS Coselli GM Vercellotti XL Wang, FEBS Lett 2006 580 2779 2787 10.1016/j.febslet.2006.04.041 16650413
22. The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. CA Zampieri JF Fortin GP Nolan GJ Nabel, J Virol 2007 81 1230 1240 17108034 10.1128/JVI.01586-06
23. Perturbation of epidermal growth factor receptor complex formation and Ras signalling in cells harbouring the hepatitis C virus subgenomic replicon. A Macdonald J Ka Yu Chan M Harris, J Gen Virol 2005 86 1027 1033 10.1099/vir.0.80724-0 15784896
24. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway. N Yoshizuka Y Yoshizuka-Chadani V Krishnan SL Zeichner, J Virol 2005 79 11366 11381 16103188 10.1128/JVI.79.17.11366-11381.2005
25. Apoptosis is induced by hantaviruses in cultured cells. JI Kang SH Park PW Lee BY Ahn, Virology 1999 264 99 105 10.1006/viro.1999.9896 10544134
26. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. A Markotic L Hensley T Geisbert K Spik C Schmaljohn, J Gen Virol 2003 84 2197 2202 10.1099/vir.0.19090-0 12867652
27. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. T Masaki R Foti PA Hill Y Ikezumi RC Atkins DJ Nikolic-Paterson, Kidney Int 2003 63 1256 1264 10.1046/j.1523-1755.2003.00874.x 12631342
28. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. S Nagao T Yamaguchi M Kusaka RL Maser H Takahashi BD Cowley JJ Grantham, Kidney Int 2003 63 427 434 10.1046/j.1523-1755.2003.00755.x 12631108
29. Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. B Kiely G Feldman MP Ryan, Kidney Int 2003 63 908 916 10.1046/j.1523-1755.2003.00804.x 12631071
30. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. JH Lipschutz S Li A Arisco DF Balkovetz, J Biol Chem 2005 280 3780 3788 10.1074/jbc.M408122200 15569684
31. Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. XD Li H Lankinen N Putkuri O Vapalahti A Vaheri, Virology 2005 333 180 189 10.1016/j.virol.2005.01.002 15708603
32. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. B Settergren, Scand J Infect Dis 2000 32 125 132 10.1080/003655400750045204 10826895
33. Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever. S Kim ET Kang YG Kim JS Han JS Lee YI Kim WC Hall JM Dalrymple CJ Peters, Am J Clin Pathol 1993 100 398 403 7692720
34. Hypophyseal hemorrhage and panhypopituitarism during Puumala virus infection: magnetic resonance imaging and detection of viral antigen in the hypophysis. T Hautala T Sironen O Vapalahti E Pääkkö T Särkioja PI Salmela A Vaheri A Plyusnin H Kauma, Clin Infect Dis 2002 35 96 101 10.1086/340859 12060884
35. Loss of cell membrane integrity in Puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Klingström J Hardestam M Stoltz B Zuber Å Lundkvist S Linder C Ahlm, J Virol 2006 80 8279 8282 16873286 10.1128/JVI.00742-06
36. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. CS Schmaljohn SE Hasty JM Dalrymple JW LeDuc HW Lee CH von Bonsdorff M Brummer-Korvenkontio A Vaheri TF Tsai HL Regnery D Goldgaber PW Lee, Science 1985 227 1041 1044 10.1126/science.2858126 2858126
37. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. O Vapalahti Å Lundkvist SK Kukkonen Y Cheng M Gilljam M Kanerva T Manni M Pejcoch J Niemimaa A Kaikusalo H Henttonen A Vaheri A Plyusnin, J Gen Virol 1996 77 3063 3067 10.1099/0022-1317-77-12-3063 9000098
38. Prolonged survival of Puumala hantavirus outside the host: evidence of indirect transmission via the environment. ER Kallio J Klingström E Gustafsson T Manni A Vaheri H Henttonen O Vapalahti Å Lundkvist, J Gen Virol 2006 87 2127 2134 10.1099/vir.0.81643-0 16847107
39. Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. O Vapalahti H Kallio-Kokko A Närvänen I Julkunen A Lundkvist A Plyusnin H Lehväslaiho M Brummer-Korvenkontio A Vaheri H Lankinen, J Med Virol 1995 46 293 303 10.1002/jmv.1890460402 7595404